| 产品详情 |
| Edit |   |
|---|
| Product Name | RKI-1447 |
|---|
| Description | A ROCK-I and II inhibitor (IC50s = 14.5 and 6.2 nM, respectively) that functions by binding to the ATP binding site of the kinase; suppresses the activation of ROCK substrates MLC-2 and the MLC phosphatase PP1 regulatory subunit MYPT1 at 100 nM in cancer cells |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1342278-90-3 1342278-94-7 ROCK inhibitor cancer migration invasion metastasis Rho-associated kinase ROCK1 ROCK2 biochemical signal transduction intracellular signaling RKI1447 ATP binding site suppress activation substrate myosin light chain MLC-2 phosphatase PP1 MLC2 regulatory subunit MYPT-1 MYPT1 mediated MDA-MB-231 breast cancer cells pyridylthiazolyl-urea |
|---|
| Gene, Accession, CAS # | CAS: 1342278-01-6 |
|---|
| Catalog # | 16278-5 |
|---|
| Price | |
|---|
| Order / More Info | RKI-1447 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|